Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Anesth Analg
2011 Mar 01;1123:568-73. doi: 10.1213/ANE.0b013e3182080599.
Show Gene links
Show Anatomy links
Does anesthetic additivity imply a similar molecular mechanism of anesthetic action at N-methyl-D-aspartate receptors?
Brosnan RJ
,
Pham TL
.
???displayArticle.abstract???
Isoflurane and carbon dioxide (CO(2)) negatively modulate N-methyl-d-aspartate (NMDA) receptors, but via different mechanisms. Isoflurane is a competitive antagonist at the NMDA receptor glycine binding site, whereas CO(2) inhibits NMDA receptor current through extracellular acidification. Isoflurane and CO(2) exhibit additive minimum alveolar concentration effects in rats, but we hypothesized that they would not additively inhibit NMDA receptor currents in vitro because they act at different molecular sites. NMDA receptors were expressed in frog oocytes and studied using 2-electrode voltage clamp techniques. A glycine concentration response for NMDA was measured in the presence and absence of CO(2). Concentration-response curves for isoflurane, H(+), CO(2), and ketamine as a function of NMDA inhibition were measured, and a Hill equation was used to calculate the EC(50) for each compound. Binary drug combinations containing ½ EC(50) were additive if NMDA current inhibition was not statistically different from 50%. The ½ EC(50) binary drug combinations decreased the percentage baseline NMDA receptor current as follows (mean ± SD, n = 5 to 6 oocytes each): CO(2)+ H(+) (51% ± 5%), CO(2 )+ isoflurane (54% ± 5%), H(+) + isoflurane (51% ± 3%), CO(2)+ ketamine (67% ± 8%), and H(+) + ketamine (64% ± 2%). In contrast to our hypothesis, NMDA receptor inhibition by CO(2) and isoflurane is additive. Possibly, CO(2) acidification modulates a pH-sensitive loop on the NMDA receptor that in turn alters glycine binding affinity on the GluN1 subunit. However, ketamine plus either CO(2) or H(+) synergistically inhibits NMDA receptor currents. Drugs acting via different mechanisms can thus exhibit additive or synergistic receptor effects. Additivity may not robustly indicate commonality between molecular anesthetic mechanisms.
Banke,
Protons trap NR1/NR2B NMDA receptors in a nonconducting state.
2005, Pubmed
Banke,
Protons trap NR1/NR2B NMDA receptors in a nonconducting state.
2005,
Pubmed
Brosnan,
Carbon dioxide negatively modulates N-methyl-D-aspartate receptors.
2008,
Pubmed
,
Xenbase
Brosnan,
Anesthetic properties of carbon dioxide in the rat.
2007,
Pubmed
Brosnan,
Ammonia has anesthetic properties.
2007,
Pubmed
,
Xenbase
Brosnan,
Chirality in anesthesia II: stereoselective modulation of ion channel function by secondary alcohol enantiomers.
2006,
Pubmed
,
Xenbase
Dickinson,
Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.
2007,
Pubmed
Eger,
Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats.
2008,
Pubmed
Eger,
Is a new paradigm needed to explain how inhaled anesthetics produce immobility?
2008,
Pubmed
Hendrickx,
Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility.
2008,
Pubmed
Hirai,
The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.
1996,
Pubmed
Hollmann,
Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
2001,
Pubmed
,
Xenbase
Jenkins,
General anesthetics have additive actions on three ligand gated ion channels.
2008,
Pubmed
,
Xenbase
Kashiwagi,
Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits.
1997,
Pubmed
Kuryatov,
Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins.
1994,
Pubmed
,
Xenbase
Low,
Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating.
2003,
Pubmed
,
Xenbase
Ogata,
Effects of anesthetics on mutant N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
2006,
Pubmed
,
Xenbase
Orser,
Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors.
1997,
Pubmed
Shafer,
Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms.
2008,
Pubmed
Solano,
Effect of intravenous administration of ketamine on the minimum alveolar concentration of isoflurane in anesthetized dogs.
2006,
Pubmed
Stabernack,
Spinal N-methyl-d-aspartate receptors may contribute to the immobilizing action of isoflurane.
2003,
Pubmed
Sullivan,
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor.
1994,
Pubmed
,
Xenbase
Tallarida,
Drug synergism: its detection and applications.
2001,
Pubmed
Traynelis,
Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines.
1995,
Pubmed
,
Xenbase
Wright,
NMDA receptor pharmacology and analysis of patch-clamp recordings.
1999,
Pubmed
Yang,
The plasticizer di(2-ethylhexyl) phthalate modulates gamma-aminobutyric acid type A and glycine receptor function.
2007,
Pubmed
,
Xenbase
Yang,
Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone.
2007,
Pubmed
,
Xenbase